Some forms of arthritis are autoimmune diseases, but most are not. Arthritis is an umbrella term covering more than 100 conditions that cause joint inflammation, stiffness, or pain. The most common type, osteoarthritis, is driven primarily by cartilage breakdown and low-grade inflammation rather than an immune system malfunction. Rheumatoid arthritis, the best-known autoimmune form, occurs when the immune system mistakenly attacks healthy joint tissue.
Which Types Are Autoimmune
In autoimmune arthritis, the body produces proteins called autoantibodies that target its own healthy tissues, triggering inflammation in and around the joints. Rheumatoid arthritis is the most recognized example. Others include psoriatic arthritis, ankylosing spondylitis (which primarily affects the spine where it meets the pelvis), and juvenile idiopathic arthritis in children. Lupus can also cause arthritis-like joint symptoms as part of its broader autoimmune process.
Rheumatoid arthritis usually develops between the ages of 30 and 60, though a form called young-onset rheumatoid arthritis can appear between 16 and 40. Women are affected more often than men. Genetics play a meaningful role: a family of genes involved in immune regulation accounts for roughly 30% of the total genetic contribution to rheumatoid arthritis risk.
Which Types Are Not Autoimmune
Osteoarthritis is by far the most common form of arthritis and is not classified as autoimmune. It was long considered a simple “wear and tear” condition, but research from Stanford Medicine has shown that low-grade inflammatory processes are a major driver. When cartilage sustains initial damage, it triggers a chain of molecular events that activates the complement system, one of the body’s key defenses against infection. In osteoarthritis, this system essentially overreacts: joint tissues show an overabundance of inflammation-accelerating proteins and a shortage of the proteins that normally put the brakes on. The result is a self-reinforcing cycle of damage and inflammation.
That said, the inflammation in osteoarthritis is far less intense than in rheumatoid arthritis. It’s a localized process tied to joint damage, not a system-wide immune malfunction. Gout is another non-autoimmune form. It results from a buildup of uric acid crystals in the joints, causing sudden, intense flares of pain and swelling.
How Autoimmune Arthritis Feels Different
The practical differences between autoimmune and non-autoimmune arthritis show up in everyday symptoms, especially in the morning. Osteoarthritis causes mild stiffness that typically fades after just a few minutes of moving around. Rheumatoid arthritis causes morning stiffness that doesn’t begin to improve for an hour or longer.
Autoimmune arthritis also tends to be symmetrical. If your left wrist is inflamed, your right wrist likely is too. Osteoarthritis is more often asymmetrical, concentrated in joints that have seen the most use or injury over time. Rheumatoid arthritis frequently targets the small joints of the hands, wrists, and feet first, while osteoarthritis gravitates toward weight-bearing joints like the knees, hips, and spine.
Perhaps the most important distinction is that autoimmune arthritis is a systemic disease. It doesn’t stop at the joints. Many people with rheumatoid arthritis develop problems in the skin, eyes, lungs, heart, and blood vessels. The chronic inflammation increases the risk of heart disease even when the joints themselves are well managed.
How Autoimmune Arthritis Is Diagnosed
Diagnosing autoimmune arthritis can be tricky, especially early on. Blood tests look for specific markers of immune activity. A CCP antibody test is one of the most useful, often paired with a rheumatoid factor (RF) test. Neither test is perfect on its own. Some people with rheumatoid arthritis have little to no rheumatoid factor in their blood, and RF can show up in people with other autoimmune conditions or even in healthy individuals. Using both tests together gives a more accurate picture.
Additional blood tests measure general inflammation levels, including C-reactive protein and erythrocyte sedimentation rate. Joint X-rays and synovial fluid analysis (examining the fluid inside a swollen joint) help round out the diagnosis. Because no single test is definitive, diagnosis typically depends on combining lab results with a physical exam and symptom history.
How Treatment Differs
Treatment for autoimmune arthritis looks fundamentally different from treatment for osteoarthritis because the underlying problem is different. When the immune system is driving the disease, the goal is to slow or suppress that immune response before it causes permanent joint damage.
The main medications for autoimmune arthritis are called disease-modifying drugs, or DMARDs. The conventional versions, taken as pills, have been used for decades and are relatively affordable. They can take several weeks or even months to reach full effect. When conventional options aren’t enough, biologic medications offer a more targeted approach. These are proteins derived from living cells that block specific parts of the immune system involved in inflammation. Because they’re too complex to compress into a pill, they’re given as injections or infusions. Biologics tend to be more expensive and carry a higher risk of infections because they suppress parts of the immune system.
Osteoarthritis management, by contrast, focuses on pain relief, maintaining joint function, and slowing cartilage loss. Anti-inflammatory pain relievers, physical therapy, weight management, and in some cases joint replacement surgery are the primary tools. There’s no equivalent of a DMARD for osteoarthritis because there’s no misdirected immune response to suppress.
How Common Each Type Is
Arthritis overall is extremely common. CDC data from 2022 puts the age-adjusted prevalence of diagnosed arthritis in U.S. adults at 18.9%, with rates climbing steeply by age: 3.6% in adults 18 to 34, rising to 53.9% in those 75 and older. Women (21.5%) are more likely than men (16.1%) to have some form of arthritis. The vast majority of these cases are osteoarthritis.
Rheumatoid arthritis is far less common, affecting roughly 1% of the population worldwide. But its impact is disproportionate because it tends to strike earlier in life, affects the whole body, and can cause irreversible joint destruction if not treated aggressively in the first months and years after diagnosis. Early diagnosis and treatment have become significantly better, and many people with autoimmune arthritis now maintain a high quality of life with proper management.